Publications

5803 Results

Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM

Authors
M Quezado;R Ronchetti;A Rapkiewicz;M Santi;D Blumenthal;EJ Rushing
Journal / Conference
Clinical Neuropathology 24(4):163-169
Year
2005
Research Committee(s)
Brain
Study Number(s)
S0001

Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: safety results from the US Intergroup phase II trial ACOSOG Z9000

Authors
RP Dematteo;CR Antonescu;V Chadaram;YN You;L McCall;R Maki;A Murgo;G Demetri;P Pisters;MF Brennan
Journal / Conference
Proc of the ASCO, JCO 23(16S):818s (#9009)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
CTSU/Z9000

Operating characteristics of prostate-specific antigen in men with an initial psa level of 3.0 ng/mL or lower

Authors
IM Thompson;DP Ankerst;C Chi;MS Lucia;PJ Goodman;JJ Crowley;HL Parnes;CA Coltman
Journal / Conference
The Journal of the American Medical Association 294(1):66-70
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

CTFG (CCN2) predicts OS and DFS in adult acute lymphoblastic leukemia

Authors
O Sala-Torra;H Gundacker;DL Stirewalt;PA Ladne;EL Pogosova-Agadjanyan;ML Slovak;CL Willman;S Heimfeld;DH Boldt;JP Radich
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #336
Year
2005
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9400

An update of a phase II trial of CHOP followed by tositumomab/iodine I-131 tositumomab (Bexxar) for front-line treatment of advanced stage, follicular lymphoma: Southwest Oncology Group Protocol 9911

Authors
OW Press;J Unger;D Maloney;RM Braziel;M LeBlanc;T Grogan;TP Miller;RI Fisher
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #352
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
S9911

Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer

Authors
T Winton;R Livingston;D Johnson;J Rigas;M Johnston;C Butts;Y Cormier;G Goss;R Inculet;E Vallieres;W Fry;D Bethune;J Ayoub;K Ding;K Seymour;B Graham;MS Tsao;D Gandara;K Kesler;T Demmy;F Shepherd
Journal / Conference
New England Journal of Medicine 352(25):2589-2597
Year
2005
Research Committee(s)
Lung
Study Number(s)
JBR10

Correlation of target kinase genotype with clinical activity of imatinib mesylate (IM) in patients with matastatic GI Stromal tumors (GISTs) expressing KIT (KIT+)

Authors
MC Heinrich;JS Shoemaker;CL Corless;D Hollis;GD Demetri;MM Bertagnolli;JA Fletcher
Journal / Conference
Proc of the ASCO, JCO 23(16S):3s (#7)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Very late antigen-4 (VLA-4) expression by AML blasts: correlation of VCAM-1 binding to overall survival

Authors
PS Becker;T Papayannopoulou;KJ Kopecky;AN Hanks;JM Harlan;CL Willman;FR Appelbaum
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #2365
Year
2005
Research Committee(s)
Leukemia

New treatment options have changed the survival of patients with follicular lymphoma

Authors
RI Fisher;M LeBlanc;OW Press;DG Maloney;JM Unger;TP Miller
Journal / Conference
Journal of Clinical Oncology 23(33):8447-8452
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427, SWOG-7713/14, SWOG-8809, S9800, S9911

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group

Authors
MK Gibson;Y Li;B Murphy;MHA Hussain;RC DeConti;J Ensley;AA Forastiere
Journal / Conference
Journal of Clinical Oncology 23(15):3562-3567
Year
2005
Research Committee(s)
Head and Neck
Study Number(s)
E1395